1. Home
  2. TACT vs ELTX Comparison

TACT vs ELTX Comparison

Compare TACT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

N/A

Current Price

$5.13

Market Cap

58.5M

Sector

Technology

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.91

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TACT
ELTX
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.5M
63.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
TACT
ELTX
Price
$5.13
$1.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$18.00
AVG Volume (30 Days)
15.0K
317.7K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
87.88
39.29
EPS
0.07
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
$10.36
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$74.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$1.71
52 Week High
$6.02
$16.00

Technical Indicators

Market Signals
Indicator
TACT
ELTX
Relative Strength Index (RSI) 49.99 28.51
Support Level $4.72 N/A
Resistance Level $5.42 $3.32
Average True Range (ATR) 0.20 0.14
MACD 0.00 -0.02
Stochastic Oscillator 42.22 22.75

Price Performance

Historical Comparison
TACT
ELTX

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: